Sarepta Therapeutics
SRPT
SRPT
305 hedge funds and large institutions have $6.08B invested in Sarepta Therapeutics in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 114 increasing their positions, 101 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more call options, than puts
Call options by funds: $158M | Put options by funds: $150M
7% less funds holding
Funds holding: 328 → 305 (-23)
30% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 63
Holders
305
Holding in Top 10
4
Calls
$158M
Puts
$150M
Top Buyers
| 1 | +$132M | |
| 2 | +$52.6M | |
| 3 | +$46.6M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$46.2M |
| 5 |
Holocene Advisors
New York
|
+$35.2M |
Top Sellers
| 1 | -$204M | |
| 2 | -$39.2M | |
| 3 | -$31.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$16M |